Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 8:9:1043840.
doi: 10.3389/fmed.2022.1043840. eCollection 2022.

Current advances in the selection of adjuvant radiotherapy regimens for keloid

Affiliations
Review

Current advances in the selection of adjuvant radiotherapy regimens for keloid

Weihao Wang et al. Front Med (Lausanne). .

Abstract

Keloid is a common benign skin tumor in the outpatient department, and patients are often accompanied by itching and pain. Since the pathogenesis is unknown, the effect of single method treatment is unsatisfactory, and therefore the recurrence rate is high. Therefore, comprehensive treatment is mostly used in clinical treatment. Adjuvant radiotherapy is currently one of the most effective treatments for keloid. After long-term clinical practice, brachytherapy and electron beam radiotherapy has increasingly become the gold standard of treatment, because brachytherapy provides more focused radiation treatment to focal tissue to significantly reduce recurrence rate, and better preserve normal tissue. With the development of new radiotherapy techniques, more options for the treatment of keloid. Currently, adjuvant radiotherapy has been widely recognized, but there is no consensus on the optimal protocol for adjuvant radiotherapy for keloids. This review provides a review of published treatment options and new radiotherapy techniques for adjuvant radiotherapy of keloids and gives a comprehensive evaluation for clinical treatment.

Keywords: adjuvant radiotherapy; dose; keloid; radiation; recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Schematic representation of the radiation technique. (A) Process and prognosis of postoperative radiotherapy for keloids, (B) mechanism of X-ray and selection of dose and depth, (C) mechanism of electron radiation and selection of dose and depth, and (D) mechanism of brachytherapy and selection of dose and depth. Reproduced with permission from Journal of Plastic, Reconstructive & Aesthetic Surgery (19).

Similar articles

Cited by

References

    1. Li W, Wang Y, Wang X, Liu ZA. Keloid edge precut, preradiotherapy method in large keloid skin graft treatment. Dermatol Surg. (2014) 40:52–7. 10.1111/dsu.12374 - DOI - PubMed
    1. Gold MH, McGuire M, Mustoe TA, Pusic A, Sachdev M, Waibel J. Updated international clinical recommendations on scar management: part 2—Algorithms for scar prevention and treatment. Dermatol Surg. (2014) 40:825–31. 10.1111/dsu.0000000000000050 - DOI - PubMed
    1. Wittenberg GP, Fabian BG, Bogomilsky JL, Schultz LR, Rudner EJ, Chaffins ML, et al. Prospective, single-blind, randomized, controlled study to assess the efficacy of the 585-nm flashlamp-pumped pulsed-dye laser and silicone gel sheeting in hypertrophic scar treatment. Arch Dermatol. (1999) 135:1049–55. 10.1001/archderm.135.9.1049 - DOI - PubMed
    1. Liu S, Yang H, Song J, Zhang Y, Abualhssain ATH, Yang B. Keloid: genetic susceptibility and contributions of genetics and epigenetics to its pathogenesis. Exp Dermatol. (2022). 10.1111/exd.14671 - DOI - PubMed
    1. Brown JJ, Bayat A. Genetic susceptibility to raised dermal scarring. Br J Dermatol. (2009) 161:8–18. 10.1111/j.1365-2133.2009.09258.x - DOI - PubMed

LinkOut - more resources